ABSTRACT
Lermoyez´ syndrome is an unusual clinical variant of Ménière's disease, because in both pathologies there is a peripheral vascular disorder, what It consists in the dilation of the labyrinthine membranes associated with an increase in the volume of the endolymph. Clinically, they have severe frequency fluctuations of hearing loss, tinnitus and vertigo attacks. FinaIly, it evolves to the deterioration of hearing in all frequencies. Lermoyez´ síndrome, or labyrinthine angiospasm, has an unknown etiopathogeny, although several theories have been proposed, but none explains its nature, nor its clinical course, being one of them the allergy. Their diagnosis is clinical, they present the typical triad (peripheral vertigo crisis with neurosensory hearing loss and tinnitus and/or otic fullness), but they characterised by the improvement in hearing just after a sudden vertigo attack. With the development of the disease, dizziness attacks and hearing recovery become more and more rare, and disappear. Treatment aims to relieve symptoms during crises and improve disease progression. It is present the clinical case of Lermoyez syndrome, in a male patient with allergic pathology, who was diagnosed with Ménière's disease at the beginning. It is a rare syndrome described described in classical ENT (ear-nose-throat)
El síndrome de Lermoyez es una variante clínica inusual de la enfermedad de Ménière. En ambas afecciones existe un trastorno vascular periférico, que consiste en la dilatación de las membranas laberínticas, asociadas con aumento del volumen de la endolinfa. Clínicamente, el individuo presenta fluctuaciones en la audición (hipoacusia neurosensorial en las frecuencias graves), acúfenos y ataques de vértigo. En su evolución final se deteriora la audición en todas las frecuencias. El síndrome de Lermoyez, o angioespasmo laberíntico, tiene una etiopatogenia desconocida, aunque se han propuesto varias teorías, pero ninguna explica su naturaleza ni su curso clínico, y una de ellas es la alergia. Su diagnóstico es clínico, presentan la triada típica (crisis de vértigo periférico con hipoacusia neurosensorial y acúfenos o plenitud ótica), pero el síndrome de Lermoyez se caracteriza por la mejora de la audición tras un ataque brusco de vértigo. Con el avance de la enfermedad, los ataques de vértigo y la recuperación de la audición llegan a ser cada vez más raros, hasta desaparecer. El tratamiento tiene como finalidad aliviar los síntomas durante las crisis y mejorar la evolución de la enfermedad. Se presenta un caso clínico de síndrome de Lermoyez, en un paciente varón con afección alérgica, cuyo diagnóstico de inicio fue de enfermedad de Ménière. Es un síndrome infrecuente, descrito en la otorrinolaringología clásica
Subject(s)
Humans , Male , Middle Aged , Otolaryngology , Vertigo , Dizziness , Hearing Loss , Meniere DiseaseABSTRACT
No disponible
Subject(s)
Humans , Male , Aged , Sarcoma, Ewing/pathology , Bone Neoplasms/pathology , Hypopharyngeal Neoplasms/pathology , Biopsy , Pyriform Sinus/pathology , Fatal OutcomeSubject(s)
Hypopharyngeal Neoplasms/pathology , Pyriform Sinus/pathology , Sarcoma, Ewing/pathology , Aged , Biopsy , Cetuximab/therapeutic use , Combined Modality Therapy , Comorbidity , Fatal Outcome , Humans , Hypopharyngeal Neoplasms/drug therapy , Hypopharyngeal Neoplasms/radiotherapy , Male , Pyriform Sinus/surgery , Sarcoma, Ewing/drug therapy , Sarcoma, Ewing/radiotherapyABSTRACT
Introducción y objetivos: La fístula faringocutánea (FFC) constituye uno de los principales problemas para los pacientes sometidos a laringectomía total. Son numerosos los factores de riesgo descritos y asociados a la aparición de la FFC, sin embargo algunos de ellos se encuentran en discusión. El objetivo es analizar la incidencia de la FFC, la estancia hospitalaria y los factores de riesgo asociados en los pacientes intervenidos de laringectomía total en un hospital de segundo nivel. Métodos: Estudio analítico observacional en una cohorte retrospectiva. Se incluyeron todos los pacientes intervenidos de laringectomía total entre los años 2006 y 2011. Se tuvieron en cuenta variables sociodemográficas, clínicas y la mayoría de los factores de riesgo estudiados en la literatura por otros autores (traqueostomía, estadificación tumoral, quimio/radioterapia previa, etc.). Los análisis estadísticos se llevaron a cabo mediante el programa SPSS® v.15.0 y el Epidat® v.3.1. Resultados: Se analizaron 70 laringectomías totales. La incidencia de FFC en el período de estudio fue del 48,6%. Hubo diferencias significativas entre la estancia hospitalaria media de los pacientes con y sin FFC. Se encontró como único factor de riesgo para la aparición de la FFC la presencia de adenopatías lo corregionales afectadas [RR= 1,60 (1,006-2,54)]. Conclusión: La aparición de FFC se encuentra asociada a la presencia de adenopatías locorregionales afectadas, y no se asocia con la traqueostomía, la administración de radio/quimioterapia previa a la intervención o la localización tumoral (AU)
Introduction and objectives: Pharyngo-cutaneous fistula (PCF) is one of the main problems for patients undergoing total laryngectomy. There are many risk factors described and associated with the appearance of PCF; however, some of these are currently under discussion. The aim of this work is to analyse the incidence of PCF, hospital stay and associated risk factors in patients undergoing total laryngectomy in a secondary hospital. Methods: This was an observational study in a retrospective cohort. We included all patients who underwent total laryngectomy between 2006 and 2011. We considered sociodemographic and clinical items, and most of the risk factors studied in the literature by other authors (tracheostomy, tumour stage, chemotherapy or radiotherapy before surgery, etc.). Statistical analyses were performed using SPSS® 15.0 and Epidat® 3.1. Results: We analysed 70 total laryngectomies. The incidence of PCF in the time period studied was 48.6%. There were significant differences between the mean hospital stay of patients with and without PCF. Affected locoregional lymph nodes were found to be the only risk factor for the occurrence of PCF [RR=1.60 (1.006-2.54)]. Conclusion: The incidence of PCF is associated with the presence of affected locoregional lymph nodes. It is not associated with tracheostomy, administration of radio/chemotherapy before surgery or tumour location (AU)
Subject(s)
Humans , Male , Female , Middle Aged , Oral Fistula/epidemiology , Cutaneous Fistula/epidemiology , Laryngectomy/adverse effects , Postoperative Complications/epidemiology , Risk Factors , Length of Stay/statistics & numerical data , Retrospective Studies , ComorbidityABSTRACT
INTRODUCTION AND OBJECTIVES: Pharyngo-cutaneous fistula (PCF) is one of the main problems for patients undergoing total laryngectomy. There are many risk factors described and associated with the appearance of PCF; however, some of these are currently under discussion. The aim of this work is to analyse the incidence of PCF, hospital stay and associated risk factors in patients undergoing total laryngectomy in a secondary hospital. METHODS: This was an observational study in a retrospective cohort. We included all patients who underwent total laryngectomy between 2006 and 2011. We considered sociodemographic and clinical items, and most of the risk factors studied in the literature by other authors (tracheostomy, tumour stage, chemotherapy or radiotherapy before surgery, etc.). Statistical analyses were performed using SPSS(®) 15.0 and Epidat(®) 3.1. RESULTS: We analysed 70 total laryngectomies. The incidence of PCF in the time period studied was 48.6%. There were significant differences between the mean hospital stay of patients with and without PCF. Affected locoregional lymph nodes were found to be the only risk factor for the occurrence of PCF [RR=1.60 (1.006-2.54)]. CONCLUSION: The incidence of PCF is associated with the presence of affected locoregional lymph nodes. It is not associated with tracheostomy, administration of radio/chemotherapy before surgery or tumour location.
Subject(s)
Cutaneous Fistula/epidemiology , Cutaneous Fistula/etiology , Laryngectomy/adverse effects , Pharyngeal Diseases/epidemiology , Pharyngeal Diseases/etiology , Respiratory Tract Fistula/epidemiology , Respiratory Tract Fistula/etiology , Female , Humans , Incidence , Laryngectomy/methods , Length of Stay , Male , Middle Aged , Retrospective Studies , Risk FactorsABSTRACT
La sarcoidosis es una enfermedad inflamatoria granulomatosa crónica multisistémica, de etiología desconocida, que afecta principalmente el aparato respiratorio, sobre todo el inferior, y a adultos jóvenes, y es rara en la vía respiratoria superior (fosas y senos paranasales, y laringe). Se manifiesta de forma muy inespecífica, con clínica secundaria a obstrucción de la vía aérea. El diagnóstico se establece cuando los hallazgos clínico-radiológicos se apoyan en granulomas tuberculoides no caseificantes. El tratamiento de base son medidas de soporte, debido a la remisión espontánea
The sarcoidosis is an inflammatory granulomatos multisystemic chronic disease of unknown etiology, that mainly affects the respiratory tract, mainly the lower one and in young adults; being rare the affectation of the upper respiratory tract (nose, paranasal sinus and larynx). It manifests with many unspecific form, and with symptoms secondary to the airways obstruction. The diagnosis is established when the clinical and radiological findings are supported in tuberculoid granulomas without caseum. The base of the treatment are support measurements due to the spontaneous remission
